[The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D002219:Carbamates; D011727:Pyridinolcarbamate; D002994:Clofibrate
Importanza dell'associazione di piridinolcarbamato e clofibrato nella terapia dell'aterosclerosi